International Zinc Association Partners With Pharmanova to Save Children in Zambia
21.1.2026 09:00:00 CET | Business Wire | Press release
Zinc Saves Kids, a global child‑health initiative of the International Zinc Association (IZA), has announced a new partnership with leading Zambian pharmaceutical manufacturer Pharmanova Zambia Limited to expand access to life‑saving zinc treatments for children across Zambia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121178091/en/

Life-saving zinc-supplementation and oral rehydration salts kits are proactively distributed to Zambian children through the works of the International Zinc Association, Pharmanova, and the Zambian Ministries of Health and Education.
The collaboration was formally celebrated during a ceremony in Lusaka with the Zambian Ministry of Health, Pharmanova Zambia Limited, and IZA represented by Environment Health & Sustainability Director Dr. Eric Van Genderen.
IZA and Pharmanova have united in an effort to scale up treatment for childhood diarrhea using zinc, an essential micronutrient that strengthens immune systems and reduces the severity and duration of diarrheal disease. The need is urgent: more than 30% of Zambia’s population is zinc‑deficient, leaving children especially vulnerable to diarrhea, pneumonia, and malaria. Globally, 116,000 children are estimated to die from zinc deficiency related issues every year.
Through this partnership, every dollar donated to Zinc Saves Kids will directly support the distribution of Kit Yamoyo, the “Kit of Life,” which includes oral rehydration salts (ORS) and a ten‑day supply of zinc tablets. Zinc and ORS are recommended by the World Health Organization for the treatment of diarrhea. Each kit provides a complete treatment for diarrhea and helps prevent future illness.
“IZA is thrilled to work with Pharmanova to address zinc deficiency, which weakens the immune systems of at‑risk children and leaves them vulnerable to diarrhea, pneumonia, and malaria,” said Dr. Van Genderen. “Zinc is critical to healthy mental and physical development, and this partnership is an important step toward improving child health in Zambia.”
The first tranche of donations already has supplied 50,000 zinc and oral rehydration kits to Zambian children. Distribution is being conducted through the government’s Healthy Learners program, which operates in schools nationwide and focuses on reaching rural and underserved communities.
Pharmanova, established in 1980, developed Kit Yamoyo to combat childhood diarrhea and has previously partnered with agencies including USAID and UNICEF to expand access to essential medicines.
“There is a great need for Kit Yamoyo across Zambia and beyond, so we are pleased to have the opportunity to work with the International Zinc Association, which has a long history of addressing zinc deficiency worldwide,” said Mohammed Umar, CEO of Pharmanova. “We envision a long and fruitful partnership with Zinc Saves Kids.”
Launched in 2010, Zinc Saves Kids works to raise awareness of global zinc deficiency and supports programs focused on supplementation, food fortification, and treatment. The partnership with Pharmanova marks a significant expansion of the initiative’s reach, which has previously raised more than $4 million to provide life-saving research, education, and treatment related to zinc.
About the International Zinc Association
The International Zinc Association (IZA) is the only organization dedicated exclusively to the interests of zinc and its users. As the voice of the global zinc industry, IZA provides global leadership, coordination, and value on strategic issues for the zinc industry, including market development, license to operate, communications, and sustainability.
About Pharmanova Zambia Limited
Pharmanova Zambia Limited has been at the forefront of the Zambian pharmaceutical manufacturing industry since 1980, providing a diverse range of essential products aimed at enhancing health, hygiene, and overall well-being for Zambia and the region. Pharmanova operates three manufacturing sites strategically located in Lusaka, the capital city of Zambia.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260121178091/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Enry’s Island Unveils “Enry’s Island Adventures”: Venture Capital Becomes a Videogame and Launches the “Strap” Movement on Kickstarter3.4.2026 09:47:00 CEST | Press release
Gaming, finance, and lifestyle merge to democratize the startup ecosystem: Enry’s Island opens 2026 applications for game development studios seeking more than just capital. Enry’s Island SpA (WBAG: EIOS), the world’s first publicly traded Venture Builder, today announced the upcoming Kickstarter launch of Enry’s Island Adventures (EIA), developed by its New York-based portfolio company, Enry’s Island Adventures LLC. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402548535/en/ The game is designed to make venture capital accessible to new generations, transforming startup creation into an engaging and social gaming experience. After three years of R&D, EIA introduces a "bleisure" model (business + leisure): players learn to launch and manage startups through gameplay that includes real business KPIs, a customizable and evolving personal island, synchronous and asynchronous multiplayer modes, social events, and community-d
SES Announces Results of the Annual General Meeting2.4.2026 16:49:00 CEST | Press release
SES (the “Company”) held the Annual General Meeting (“AGM”) of Shareholders today in Betzdorf, Luxembourg. Following the recommendations made by the Board of Directors of SES, the shareholders have voted in favor of all resolutions, including the Company’s 2025 annual accounts and the proposed annual dividend of EUR 0.50 per A-share (EUR 0.20 per B-share). The total dividend amount comprises the interim dividend of EUR 0.25 per A-share (EUR 0.10 per B-share), which has already been paid to shareholders on October 16, 2025. The final dividend of EUR 0.25 per A-share (EUR 0.10 per B-share) will be paid to shareholders on April 16, 2026. “I would like to sincerely thank our shareholders for their active engagement, visionary support and continued confidence in SES’ strategy,” said Adel Al-Saleh, CEO of SES. “The outcomes of today’s AGM underscore our shared commitment to a bold multi-orbit approach, with Medium Earth Orbit as the strategic backbone of a dynamically evolving global interco
Andersen Consulting styrker sine kompetencer med tilføjelsen af Lukkap2.4.2026 16:31:00 CEST | Pressemeddelelse
Andersen Consulting tilføjer samarbejdspartneren Lukkap, et konsulenthus med fokus på oplevelsesdrevne kompetencer, der er tilpasset kundernes skiftende behov inden for transformation af medarbejdere, kunder og det digitale område. Lukkap, der blev stiftet i 2009 og har hovedsæde i Spanien, leverer integrerede løsninger, der hjælper organisationer med at transformere, hvordan de betjener kunder, engagerer medarbejdere og frigør værdi gennem adfærdsindsigt og dataanalyse. Virksomhedens tværfaglige tilgang spænder over nytænkning af kunderejsen, effektive programmer for medarbejderoplevelser, talent- og ledelsesudvikling, prædiktiv analyse samt omfattende outplacement- og transitionsydelser. Lukkap arbejder på tværs af sektorer — herunder sundhedsvæsen, medicinalindustri, forbrugsgoder, detailhandel, finans og bankvæsen — for at opbygge menneskecentrerede strategier, der skaber målbare forretningsresultater. "Ved at kombinere vores erfaringsdrevne metode med Andersen Consultings globale
Forrester: Three Years Into GenAI, Enterprises Are Still Chasing Its True Transformative Value2.4.2026 16:00:00 CEST | Press release
Low AI fluency, uneven adoption, and marginal productivity gains are limiting enterprise-scale impact According to Forrester’s (Nasdaq: FORR) latest report, Accelerate Your AI Voyage, most enterprises are struggling to turn growing AI adoption and investment into measurable business impact. One of the key factors holding businesses back is low artificial intelligence quotient (AIQ) — Forrester’s measure of AI aptitude — with many employees lacking a clear understanding of how to use AI. Other barriers include an overemphasis on productivity-focused use cases, difficulty measuring impact, and siloed adoption within individual functions. While these challenges can leave firms frozen in doubt or indecision, the wait-and-see approach to AI adoption is no longer viable. To unlock AI’s full potential, organizations need to focus on four key areas: Define the business outcomes and success metrics for what they want AI to achieve; identify specific use cases for AI deployment aligned to those
The LYCRA Company Announces Strategic Partnership on Renewable LYCRA® Fiber2.4.2026 15:00:00 CEST | Press release
Agreement with Texhong Advances Sustainable Fiber Applications The LYCRA Company, a global leader in innovative and sustainable fiber solutions for the apparel and personal care industries, today announced the signing of a strategic partnership agreement with Texhong International Group Limited (“Texhong”), one of the world’s largest suppliers of core-spun cotton textiles. Under the agreement, Texhong will exclusively partner with The LYCRA Company to bring Renewable LYCRA® fiber made with 30 percent plant-based content* to China’s core-spun yarn sector. This collaboration aims to accelerate the adoption of bio-derived spandex across the global apparel and textile industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402505834/en/ The LYCRA Company announced a strategic partnership with Texhong International Group for renewable LYCRA® fiber. Pictured at the signing ceremony held in Shanghai (left to right): Jason Wang,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom